ArticleMembranes2025
The Use of Low-Rejection Nanofiltration Membranes as a Tool to Simplify Pretreatment, Escape Scaling and Radically Increase Recoveries.
Article in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article describes the results of research to develop a new technology to treat storm and drainage water generated on a territory of industrial enterprises and reuse it as a feed water for boiler feed and steam generation. To develop such a system, it is necessary to resolve issues related to pretreatment, scaling, and fouling, as well as to provide a minimal discharge in the company's sanitation network. Principles of the new approach to reach high calcium removal are based on the use of two or three stages of low-pressure nanofiltration membranes instead of the conventional facilities that contain one stage of reverse osmosis membranes. High permeability, low pressure, high recovery, and reduced reagent consumption provide an economic effect. The technology uses low-rejection membranes "nano NF" developed and produced by "Membranium Co." (Vladimir, Russia). In the article, the results of investigations on the evaluation of scaling rates in membrane modules and rates of homogeneous crystallization in concentrate flow are presented. Processing these results enables us to detect recovery values when scaling begins on the membrane surface as well as to determine the maximum recovery value for the beginning of homogenous nucleation in the concentrate flow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.